Skip to content

Envoy Medical COCH Enterprise value

Enterprise value at other companies

Inspire Medical Systems logo
Inspire Medical SystemsINSP
$1.42B-70.0%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Calculated from Envoy Medical’s reported figures.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's enterprise value?
Envoy Medical (COCH) reported enterprise value of $16.31M in Q4 2025.
How has Envoy Medical's enterprise value changed year-over-year?
Envoy Medical's enterprise value decreased by 33.2% year-over-year, from $24.41M to $16.31M.
What is the long-term trend for Envoy Medical's enterprise value?
Over 2 years (2023 to 2025), Envoy Medical's enterprise value has grown at a -28.5% compound annual growth rate (CAGR), from $31.87M to $16.31M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.